Aros Pharma Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Employees
  • 10
  • Latest Deal Type
  • Liquidation

Aros Pharma General Information


Developer of a therapy for the treatment of gastrointestinal pain. The company develops therapies to treat the pain associated with irritable bowel syndrome by using chemicals that adversely modulates the activity of acid sensors in the gastrointestinal tract.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Primary Office
  • Ole Måløes Vej 3
  • 2200 Copenhagen
  • Denmark
+45 28 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aros Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 01-Jan-2015 Completed Bankruptcy: Liquidation
1. Early Stage VC 01-Nov-2011 Completed Startup
To view Aros Pharma’s complete valuation and funding history, request access »

Aros Pharma Executive Team (3)

Name Title Board Seat Contact Info
Henrik Blou Chief Executive Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Aros Pharma Board Members (4)

Name Representing Role Since
Mads Axelsen MD Self Board Member 000 0000
You’re viewing 1 of 4 board members. Get the full list »

Aros Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial